Tuesday, March 12, 2013

Spironolactone in diastolic heart failure


Pathophysiologic rationale and surrogate endpoints look promising but that's as far as we've come so far.  A long journey awaits.  The latest study in JAMA.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)